Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
47 hedge funds and large institutions have $132M invested in Axcella Health Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 10
14% more capital invested
Capital invested by funds: $116M → $132M (+$16.5M)
12% more funds holding
Funds holding: 42 → 47 (+5)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$843K |
| 2 |
Bank of New York Mellon
New York
|
+$268K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$255K |
| 4 |
BlackRock
New York
|
+$214K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$190K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
-$252K |
| 2 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
-$181K |
| 3 |
Millennium Management
New York
|
-$63.5K |
| 4 |
Morgan Stanley
New York
|
-$62.4K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$40.2K |
AXLA Hedge Fund Activity: Q4 2020 in Review
47 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q4 2020, worth a combined $132M — up 14% from $116M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new AXLA positions and 1 closed out — a net gain of 5 holders — while 20 added to existing stakes and 10 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $843K. The largest seller was Squarepoint, cutting an estimated $252K.
- 47 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q4 2020, up from 42 in Q3 2020.
- Funds reported $132M of Axcella Health Inc. Common Stock stock for Q4 2020, up 14% quarter-over-quarter.
- 6 funds opened new Axcella Health Inc. Common Stock positions in Q4 2020 and 1 closed out, a net change of +5 holders.
- The largest Axcella Health Inc. Common Stock buyer in Q4 2020 was Fidelity Investments, an estimated $843K added.
- The largest Axcella Health Inc. Common Stock seller in Q4 2020 was Squarepoint, an estimated $252K sold.
Based on aggregated 13F filings for Q4 2020.